Island Pharmaceuticals Limited

ASX:ILA Stock Report

Market Cap: AU$28.1m

Island Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:ILA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Dec 24BuyAU$631,476Mwp Partners LimitedCompany9,021,214AU$0.07
04 Dec 24BuyAU$420,984Daniel TillettIndividual6,014,143AU$0.07
27 Nov 24SellAU$79,858Jason CarrollIndividual410,680AU$0.25
10 Oct 24BuyAU$443,149William GarnerIndividual6,330,747AU$0.07
09 Oct 24SellAU$46,025Jason CarrollIndividual368,575AU$0.15
27 Aug 24BuyAU$18,771Jason CarrollIndividual299,500AU$0.068
13 Jun 24SellAU$144,530Jason CarrollIndividual2,310,000AU$0.064
02 May 24BuyAU$5,520Jason CarrollIndividual100,000AU$0.055
28 Mar 24BuyAU$458,580Jason CarrollIndividual7,649,075AU$0.061
26 Mar 24BuyAU$2,014Paul Donald MacLemanIndividual33,572AU$0.06
26 Mar 24BuyAU$2,400David BrookesIndividual40,000AU$0.06
26 Mar 24BuyAU$31,235David FosterIndividual520,588AU$0.06
26 Mar 24BuyAU$2,400Anna LavelleIndividual40,000AU$0.06
26 Mar 24BuyAU$10,000KESA Partners, Inc.Company166,667AU$0.06

Insider Trading Volume

Insider Buying: ILA insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ILA?
Owner TypeNumber of SharesOwnership Percentage
Institutions00%
Private Companies4,343,6652.79%
VC/PE Firms11,104,0347.12%
Hedge Funds20,891,36513.4%
General Public26,123,81816.8%
Individual Insiders93,457,82759.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 91.9%.

Top Shareholders

Top 25 shareholders own 82.93% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.2%
William Garner
28,386,852AU$5.1m28.7%no data
16.4%
Jason Carroll
25,591,981AU$4.6m6.32%no data
13.4%
Mwp Partners Limited
20,891,365AU$3.8m0%no data
9.06%
Daniel Tillett
14,127,577AU$2.5m0%no data
7.12%
KESA Partners, Inc.
11,104,034AU$2.0m0%no data
3.74%
David Foster
5,823,872AU$1.0m0%no data
2.69%
Neville Miles
4,190,905AU$754.4k247%no data
1.49%
Ariel King
2,322,565AU$418.1k0%no data
1.18%
Andre Fraga
1,832,947AU$329.9k0%no data
1.16%
Donesk Family Trust
1,810,000AU$325.8k0%no data
1.08%
Christopher Ntoumenopoulos
1,689,136AU$304.0k0%no data
0.96%
Timothy Stephen Hanlon
1,500,000AU$270.0k0%no data
0.76%
Patricia Almeida
1,189,051AU$214.0k79.9%no data
0.75%
Catherine Hyles
1,171,999AU$211.0k0%no data
0.71%
Reid Group Developments Pty Ltd
1,109,165AU$199.6k0%no data
0.68%
Visha Holdings Pty Ltd
1,064,500AU$191.6k0%no data
0.64%
Jennifer Ciro
1,000,000AU$180.0k194%no data
0.6%
Niv Dagan
937,316AU$168.7k0%no data
0.42%
Angela Walker
647,500AU$116.6k47%no data
0.42%
Andrew Walker
647,500AU$116.6k47%no data
0.32%
Terence Tobin
500,000AU$90.0k0%no data
0.32%
Elizabeth Tobin
500,000AU$90.0k0%no data
0.32%
Ingrid Ismail
500,000AU$90.0k0%no data
0.32%
Yusuf Ismail
500,000AU$90.0k0%no data
0.17%
Lynch Thinking Investments Pty Ltd
260,000AU$46.8k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 19:48
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Island Pharmaceuticals Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rosemary CumminsMST Financial Services Pty Limited